Understanding Competition in U.S. Prescription Drug Markets: Entry and Supply Chain Dynamics #00350

Submission Number:
00350
Commenter:
Lavan Odapally
State:
Michigan
Initiative Name:
Understanding Competition in U.S. Prescription Drug Markets: Entry and Supply Chain Dynamics
Dear sir, These Pbms are making consumers pay more for their prescriptions. They are saying collecting money from the patients via Pharmacies. They are not even paying the cost of the medication.they call it as MAC price I do not know where they get these prices. I have not seen a positive change even after several months of appealing. They come with new DIR fees they are collecting after sale. 1 simple method of pay just pay the usual cost of medicine + 20% of mark up and some dispensing fee. Pharmacy is also service based business it has to serive and do the best customer service which is lacking in the big chains. Thanks for listening.